Source: BioPortfolio

Mironid Limited: Mironid Ltd Pharmaceuticals Healthcare Deals and Alliances Profile Report Updated 12102017 Prices from USD $250

SummaryMironid Ltd Mironid is a drug discovery company that develops drug candidate molecules by modulating the activity of key phosphodiesterase 4 PDE4 enzymes. The company provides pipeline products such as Novel ShoLo and Novel LoAc. Mironid uses Mirror...

Read full article »

Mironid Limited's Competitors | Mironid Limited's News | Mironid Limited's Financials

Followers on Owler

Est. Annual Revenue

$100K-5.0M

Est. Employees

1-25

CEO

Neil Wilkie

CEO Approval Rating

84/100

Mironid is a Scotland-based biopharmaceutical company that researches and develops small-molecule therapeutics for the treatment of autosomal dominant polycystic kidney disease.